MoonLake Immunotherapeutics Shares Rise on Positive Pipeline Update
**Lead:** MoonLake Immunotherapeutics' shares surge in premarket trading after announcing promising results from a Phase 2 study of sonelokimab...
Phase 3 studies
Immuron Shares Soar on Positive Travelan Study
**Lead:** U.S.-listed shares of Immuron skyrocketed over 100% in premarket trading following groundbreaking results from a Phase 2 study...
Apellis Pharmaceuticals Receives Negative Opinion for Intravitreal Pegcetacoplan
In a blow to Apellis Pharmaceuticals, the European Medicines Agency has rejected the marketing authorization application for intravitreal pegcetacoplan,...
Sagimet Biosciences Soars on Positive NASH Study Results
Sagimet Biosciences, a clinical-stage biopharmaceutical company, saw its stock more than double and reach an all-time high after reporting...
Praxis Precision Medicines Shares Rise 23% on Positive Portfolio Update
Praxis Precision Medicines saw a 23% increase in shares, reaching $31, after providing an update on its portfolio. The...
Bayer’s Elinzanetant Shows Positive Results in Menopause Drug Trials
German pharmaceutical company Bayer has announced that its menopause drug, Elinzanetant, has successfully met the primary endpoints of its...
Vertex Pharmaceuticals Stock Soars on Promising Non-Opioid Painkiller
Vertex Pharmaceuticals Inc. shares are soaring after the company released new data from a trial of its non-opioid pain...
Mixed Results from Pfizer’s Obesity Pill Study
Pfizer's Phase 2b study of its obesity pill, danuglipron, has yielded mixed results. While the study showed a significant...
Tenax Therapeutics Shares Double as FDA Clears IND for TNX-103
In a major development, Tenax Therapeutics has received clearance from the FDA for its Investigational New Drug Application for...
Celldex Shares Soar on Successful Phase 2 Study of Barzolvolimab
Celldex Therapeutics shares surged over 30% in premarket trading after the company announced positive results from a Phase 2...